- Home
- ADAP vs MASS Comparison
ADAP vs MASS Comparison
Compare ADAP & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAP
- MASS
- Stock Information
- Founded
- ADAP 2008
- MASS 2012
- Country
- ADAP United Kingdom
- MASS United States
- Employees
- ADAP N/A
- MASS N/A
- Industry
- ADAP Biotechnology: Pharmaceutical Preparations
- MASS Medical/Dental Instruments
- Sector
- ADAP Health Care
- MASS Health Care
- Exchange
- ADAP Nasdaq
- MASS Nasdaq
- Market Cap
- ADAP 71.6M
- MASS 84.3M
- IPO Year
- ADAP 2015
- MASS 2020
- Fundamental
- Price
- ADAP $0.21
- MASS $4.04
- Analyst Decision
- ADAP Strong Buy
- MASS Buy
- Analyst Count
- ADAP 5
- MASS 3
- Target Price
- ADAP $1.93
- MASS $5.33
- AVG Volume (30 Days)
- ADAP 2.4M
- MASS 8.1M
- Earning Date
- ADAP 03-20-2025
- MASS 03-04-2025
- Dividend Yield
- ADAP N/A
- MASS N/A
- EPS Growth
- ADAP N/A
- MASS N/A
- EPS
- ADAP N/A
- MASS N/A
- Revenue
- ADAP $178,032,000.00
- MASS $59,631,000.00
- Revenue This Year
- ADAP N/A
- MASS $12.79
- Revenue Next Year
- ADAP $56.87
- MASS $28.91
- P/E Ratio
- ADAP N/A
- MASS N/A
- Revenue Growth
- ADAP 195.34
- MASS 18.72
- 52 Week Low
- ADAP $0.20
- MASS $1.81
- 52 Week High
- ADAP $1.55
- MASS $7.56
- Technical
- Relative Strength Index (RSI)
- ADAP 14.09
- MASS 56.48
- Support Level
- ADAP $0.26
- MASS $3.89
- Resistance Level
- ADAP $0.47
- MASS $4.70
- Average True Range (ATR)
- ADAP 0.04
- MASS 0.52
- MACD
- ADAP -0.02
- MASS -0.04
- Stochastic Oscillator
- ADAP 1.23
- MASS 57.30
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70 and others for multiple cancer types.
About MASS 908 Devices Inc.
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.